The Motor Neurone Disease Behaviour Scale (MiND-B) is a valid, sensitive and short instrument that detects and quantifies behavioural changes in Amyotrophic Lateral Sclerosis (ALS). It measures three behavioural domains: apathy, disinhibition and stereotypical behaviour. The questionnaire contains 9 questions with a total score of 36, which higher scores denoting absence or very mild behavioural symptoms. The MiND-B can be completed by a caregiver/family member or clinician.
The MiND instrument and scoring guide can be downloaded below:
Wear, H.J., et al., The Cambridge Behavioural Inventory revised. Dementia & Neuropsychologia, 2008. 2(2): p. 102-107.
Neumann, M., et al., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006. 314(5796): p. 130-3.
Lillo, P., et al., Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotrophic Lateral Sclerosis, 2012. 13(1): p. 102-9.
Lillo, P., et al., Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS ONE, 2012. 7(8): p. e43993.
Stewart, H., et al., Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathologica, 2012. 123(3): p. 409-17.
Mioshi, E., et al., Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology, 2014. 82(2): p. 149-55.
Mioshi, E., et al., A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 2014. 15(3-4): p. 298-304.
Hsieh, S., et al., The Mini-Addenbrooke’s Cognitive Examination: A new assessment tool for dementia. Dementia and Geriatric Cognitive Disorders, 2014. 39(1-2): p. 1-11.
NeuRA is coordinating the Sydney site for the DIAN (Dominantly Inherited Alzheimer Network). This study sets out to look for biological changes that occur in people before they develop the Alzheimer’s symptoms such as memory loss. Over the last two years, NeuRA has been working on a clinical trial program aimed at preventing the symptoms of Alzheimer’s by removing amyloid […]